107 related articles for article (PubMed ID: 20372058)
1. Control of contact-inhibition by 4E-BP1 upregulation.
Azar R; Susini C; Bousquet C; Pyronnet S
Cell Cycle; 2010 Apr; 9(7):1241-5. PubMed ID: 20372058
[TBL] [Abstract][Full Text] [Related]
2. Contribution of HIF-1α in 4E-BP1 gene expression.
Azar R; Lasfargues C; Bousquet C; Pyronnet S
Mol Cancer Res; 2013 Jan; 11(1):54-61. PubMed ID: 23175522
[TBL] [Abstract][Full Text] [Related]
3. Loss of 4E-BP1 function induces EMT and promotes cancer cell migration and invasion via cap-dependent translational activation of snail.
Cai W; Ye Q; She QB
Oncotarget; 2014 Aug; 5(15):6015-27. PubMed ID: 24970798
[TBL] [Abstract][Full Text] [Related]
4. Snail determines the therapeutic response to mTOR kinase inhibitors by transcriptional repression of 4E-BP1.
Wang J; Ye Q; Cao Y; Guo Y; Huang X; Mi W; Liu S; Wang C; Yang HS; Zhou BP; Evers BM; She QB
Nat Commun; 2017 Dec; 8(1):2207. PubMed ID: 29263324
[TBL] [Abstract][Full Text] [Related]
5. Cyclin-dependent kinase 4 inhibits the translational repressor 4E-BP1 to promote cap-dependent translation during mitosis-G1 transition.
Mitchell DC; Menon A; Garner AL
FEBS Lett; 2020 Apr; 594(8):1307-1318. PubMed ID: 31853978
[TBL] [Abstract][Full Text] [Related]
6. Regulation of cyclin D1 expression by mTORC1 signaling requires eukaryotic initiation factor 4E-binding protein 1.
Averous J; Fonseca BD; Proud CG
Oncogene; 2008 Feb; 27(8):1106-13. PubMed ID: 17724476
[TBL] [Abstract][Full Text] [Related]
7. Pharmacologic co-inhibition of Mnks and mTORC1 synergistically suppresses proliferation and perturbs cell cycle progression in blast crisis-chronic myeloid leukemia cells.
Teo T; Yu M; Yang Y; Gillam T; Lam F; Sykes MJ; Wang S
Cancer Lett; 2015 Feb; 357(2):612-23. PubMed ID: 25527453
[TBL] [Abstract][Full Text] [Related]
8. The effect of p-4E-BP1 and p-eIF4E on cell proliferation in a breast cancer model.
Pons B; Peg V; Vázquez-Sánchez MA; López-Vicente L; Argelaguet E; Coch L; Martínez A; Hernández-Losa J; Armengol G; Ramon Y Cajal S
Int J Oncol; 2011 Nov; 39(5):1337-45. PubMed ID: 21750861
[TBL] [Abstract][Full Text] [Related]
9. 4E-BP1 is a target of Smad4 essential for TGFbeta-mediated inhibition of cell proliferation.
Azar R; Alard A; Susini C; Bousquet C; Pyronnet S
EMBO J; 2009 Nov; 28(22):3514-22. PubMed ID: 19834456
[TBL] [Abstract][Full Text] [Related]
10. Expression and phosphorylation of eukaryotic translation initiation factor 4E binding protein 1 in B-cell lymphomas and reactive lymphoid tissues.
Kodali D; Rawal A; Ninan MJ; Patel MR; Mesa H; Knapp D; Schnitzer B; Kratzke RA; Gupta P
Arch Pathol Lab Med; 2011 Mar; 135(3):365-71. PubMed ID: 21366462
[TBL] [Abstract][Full Text] [Related]
11. Phenethyl isothiocyanate, a cancer chemopreventive constituent of cruciferous vegetables, inhibits cap-dependent translation by regulating the level and phosphorylation of 4E-BP1.
Hu J; Straub J; Xiao D; Singh SV; Yang HS; Sonenberg N; Vatsyayan J
Cancer Res; 2007 Apr; 67(8):3569-73. PubMed ID: 17440067
[TBL] [Abstract][Full Text] [Related]
12. AKT inhibition overcomes rapamycin resistance by enhancing the repressive function of PRAS40 on mTORC1/4E-BP1 axis.
Mi W; Ye Q; Liu S; She QB
Oncotarget; 2015 Jun; 6(16):13962-77. PubMed ID: 25961827
[TBL] [Abstract][Full Text] [Related]
13. Mitotic protein kinase CDK1 phosphorylation of mRNA translation regulator 4E-BP1 Ser83 may contribute to cell transformation.
Velásquez C; Cheng E; Shuda M; Lee-Oesterreich PJ; Pogge von Strandmann L; Gritsenko MA; Jacobs JM; Moore PS; Chang Y
Proc Natl Acad Sci U S A; 2016 Jul; 113(30):8466-71. PubMed ID: 27402756
[TBL] [Abstract][Full Text] [Related]
14. Phosphatidylinositol 3-kinase-dependent transcriptional silencing of the translational repressor 4E-BP1.
Azar R; Najib S; Lahlou H; Susini C; Pyronnet S
Cell Mol Life Sci; 2008 Oct; 65(19):3110-7. PubMed ID: 18810319
[TBL] [Abstract][Full Text] [Related]
15. Stabilization of 4E-BP1 by PI3K kinase and its involvement in CHK2 phosphorylation in the cellular response to radiation.
Yu ZJ; Luo HH; Shang ZF; Guan H; Xiao BB; Liu XD; Wang Y; Huang B; Zhou PK
Int J Med Sci; 2017; 14(5):452-461. PubMed ID: 28539821
[No Abstract] [Full Text] [Related]
16. CDK1 substitutes for mTOR kinase to activate mitotic cap-dependent protein translation.
Shuda M; Velásquez C; Cheng E; Cordek DG; Kwun HJ; Chang Y; Moore PS
Proc Natl Acad Sci U S A; 2015 May; 112(19):5875-82. PubMed ID: 25883264
[TBL] [Abstract][Full Text] [Related]
17. The mTOR target 4E-BP1 contributes to differential protein expression during normoxia and hypoxia through changes in mRNA translation efficiency.
Magagnin MG; van den Beucken T; Sergeant K; Lambin P; Koritzinsky M; Devreese B; Wouters BG
Proteomics; 2008 Mar; 8(5):1019-28. PubMed ID: 18219697
[TBL] [Abstract][Full Text] [Related]
18. Association between LRRK2 and 4E-BP1 protein levels in normal and malignant cells.
Pons B; Armengol G; Livingstone M; López L; Coch L; Sonenberg N; Ramón y Cajal S
Oncol Rep; 2012 Jan; 27(1):225-31. PubMed ID: 21922152
[TBL] [Abstract][Full Text] [Related]
19. Mitotic 4E-BP1 hyperphosphorylation and cap-dependent translation.
Shuda M; Chang Y; Moore PS
Cell Cycle; 2015; 14(19):3005-6. PubMed ID: 26496165
[No Abstract] [Full Text] [Related]
20. Icariside II, a natural mTOR inhibitor, disrupts aberrant energy homeostasis via suppressing mTORC1-4E-BP1 axis in sarcoma cells.
Zhang C; Yang L; Geng YD; An FL; Xia YZ; Guo C; Luo JG; Zhang LY; Guo QL; Kong LY
Oncotarget; 2016 May; 7(19):27819-37. PubMed ID: 27056897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
